Circio Holding ASA

OB:CRNA Stok Raporu

Piyasa değeri: NOK 16.4m

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Circio Holding Yönetim

Yönetim kriter kontrolleri 4/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Erik Wiklund

İcra Kurulu Başkanı

NOK 2.6m

Toplam tazminat

CEO maaş yüzdesi95.7%
CEO görev süresi3yrs
CEO sahipliği0.6%
Yönetim ortalama görev süresi3yrs
Yönetim Kurulu ortalama görev süresi4.3yrs

Son yönetim güncellemeleri

Circio Holding ASA's (OB:CRNA) CEO Will Probably Struggle To See A Pay Rise This Year

May 29
Circio Holding ASA's (OB:CRNA) CEO Will Probably Struggle To See A Pay Rise This Year

Recent updates

Circio Holding ASA's (OB:CRNA) CEO Will Probably Struggle To See A Pay Rise This Year

May 29
Circio Holding ASA's (OB:CRNA) CEO Will Probably Struggle To See A Pay Rise This Year

Targovax ASA's (OB:TRVX) Intrinsic Value Is Potentially 96% Above Its Share Price

Aug 24
Targovax ASA's (OB:TRVX) Intrinsic Value Is Potentially 96% Above Its Share Price

Health Check: How Prudently Does Targovax (OB:TRVX) Use Debt?

Jul 08
Health Check: How Prudently Does Targovax (OB:TRVX) Use Debt?

Is Targovax (OB:TRVX) Using Debt In A Risky Way?

Oct 27
Is Targovax (OB:TRVX) Using Debt In A Risky Way?

Is Targovax (OB:TRVX) A Risky Investment?

Jul 05
Is Targovax (OB:TRVX) A Risky Investment?

Shareholders May Be A Bit More Conservative With Targovax ASA's (OB:TRVX) CEO Compensation For Now

Mar 10
Shareholders May Be A Bit More Conservative With Targovax ASA's (OB:TRVX) CEO Compensation For Now

Is Targovax (OB:TRVX) Using Debt In A Risky Way?

Feb 20
Is Targovax (OB:TRVX) Using Debt In A Risky Way?

The Chief Scientific Officer of Targovax ASA (OB:TRVX), Victor Levitsky, Just Bought A Few More Shares

Dec 05
The Chief Scientific Officer of Targovax ASA (OB:TRVX), Victor Levitsky, Just Bought A Few More Shares

CEO Tazminat Analizi

Erik Wiklund'un ücretlendirmesi Circio Holding'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

NOK 9m

Mar 31 2024n/an/a

-NOK 51m

Dec 31 2023NOK 3mNOK 2m

-NOK 111m

Sep 30 2023n/an/a

-NOK 446m

Jun 30 2023n/an/a

-NOK 449m

Mar 31 2023n/an/a

-NOK 440m

Dec 31 2022NOK 4mNOK 3m

-NOK 433m

Sep 30 2022n/an/a

-NOK 107m

Jun 30 2022n/an/a

-NOK 110m

Mar 31 2022n/an/a

-NOK 106m

Dec 31 2021NOK 3mNOK 2m

-NOK 98m

Sep 30 2021n/an/a

-NOK 98m

Jun 30 2021n/an/a

-NOK 97m

Mar 31 2021n/an/a

-NOK 105m

Dec 31 2020NOK 3mNOK 2m

-NOK 108m

Sep 30 2020n/an/a

-NOK 117m

Jun 30 2020n/an/a

-NOK 120m

Mar 31 2020n/an/a

-NOK 132m

Dec 31 2019NOK 2mNOK 2m

-NOK 148m

Sep 30 2019n/an/a

-NOK 153m

Jun 30 2019n/an/a

-NOK 162m

Mar 31 2019n/an/a

-NOK 153m

Dec 31 2018NOK 2mNOK 2m

-NOK 147m

Sep 30 2018n/an/a

-NOK 139m

Jun 30 2018n/an/a

-NOK 132m

Mar 31 2018n/an/a

-NOK 129m

Dec 31 2017NOK 942kNOK 883k

-NOK 122m

Tazminat ve Piyasa: Erik 'ın toplam tazminatı ($USD 245.26K ) Norwegian pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 314.60K ).

Tazminat ve Kazançlar: Erik 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Erik Wiklund

3yrs

Görev süresi

NOK 2,603,000

Tazminat

Dr. Erik Digman Wiklund serves as Chief Executive Officer of Circio Holding ASA (formerly known as Targovax ASA) since October 2021 and had been its Chief Business Officer since September 24, 2018 until Oc...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Erik Wiklund
Chief Executive Officer3yrsNOK 2.60m0.59%
NOK 96.3k
Lubor Gaal
CFO & Head of BD2.6yrsNOK 2.88m0.38%
NOK 62.7k
Ola Melin
Chief Operating Officerless than a yearNOK 1.97m0.20%
NOK 32.5k
Thomas Hansen
Chief Technology Officerless than a yearNOK 1.97m0.19%
NOK 31.4k
Victor Levitsky
Chief Scientific Officer4.4yrsNOK 790.00k0.19%
NOK 31.6k
Jon Eriksen
Special Advisor6.8yrsNOK 1.86mVeri yok
Gustav Gaudernack
Chief Scientific Adviserno dataVeri yokVeri yok
Peter Skorpil
Vice President of Business Development9.5yrsNOK 1.07mVeri yok

3.0yrs

Ortalama Görev Süresi

Deneyimli Yönetim: CRNA 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3 yıldır).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Diane Mellett
Independent Non-Executive Director9.1yrsNOK 371.00k0.53%
NOK 87.4k
Thomas Falck
Director2.5yrsNOK 357.00k0.38%
NOK 62.7k
Robert Burns
Independent Director9.3yrsNOK 352.00k0.28%
NOK 45.9k
Damian Marron
Chairman of the Board4.5yrsNOK 589.00k0.69%
NOK 113.4k
Dmitriy Zamarin
Member of Medical Advisory Board4yrsVeri yokVeri yok
Dean Fennell
Member of Scientific Advisory Board4yrsVeri yokVeri yok

4.3yrs

Ortalama Görev Süresi

63yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: CRNA 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 4.3 yıldır).